Clin2
NCT07305220Possibly a fitNot yet recruiting

Safety of ultrasound-guided lung biopsy for interstitial lung disease

Interstitial Lung Disease (ILD)

Part of Lungs & breathing clinical trials.

This study tests a lung biopsy method that uses ultrasound to guide a needle through the chest wall to take a small tissue sample. The goal is to see if it's safe for people with diffuse interstitial lung disease, which may help doctors get a more accurate diagnosis.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
15 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with diffuse interstitial lung disease (a condition that causes lung scarring or inflammation) and your doctor has recommended a biopsy to help with diagnosis.
  • A team of specialists has approved the biopsy for you.
  • You are not currently on long-term oxygen therapy, and your lung function tests are not severely low (above certain thresholds).
  • You do not have severe bleeding problems, very high blood pressure in the lungs, or a body mass index (BMI) over 35.
  • You are not allergic to anesthetics and are not pregnant (for women who still have periods, a pregnancy test is required).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07627594Not yet recruiting
Bronchoscopy safety in interstitial lung disease

This study checks how safe bronchoscopy is for people with interstitial lung disease (ILD), a condition that scars the lungs. It aims to provide better information to help doctors and patients decide if this procedure is right for them.

Paris
NCT07500818Recruiting
Robot vs. standard scope for lung biopsy in ILD

This study compares a robotic-assisted bronchoscope to a conventional one for performing a lung biopsy (cryobiopsy) in people with interstitial lung disease. The goal is to see which method is better at getting enough tissue for a diagnosis.

Lucerne, Canton of Lucerne
NCT07482917Recruiting
Streamlining the diagnosis of interstitial lung disease

This study is testing a new way to speed up the diagnosis of interstitial lung disease (a group of lung scarring conditions). If you have symptoms or scan findings that suggest ILD but haven't been fully diagnosed yet, this trial may help you get a faster, clearer answer.

Granollers, Barcelona
NCT07615504Recruiting
Better diagnostic testing for interstitial lung disease

This research study tests new diagnostic methods to better identify and predict outcomes in interstitial lung disease (a group of lung conditions causing scarring and breathing problems). Researchers are looking for people with ILD or those exposed to pigeons, which can trigger a type of lung disease.

Blackpool
NCT06235645Recruiting
Detecting lung disease in rheumatoid arthritis with ultrasound

This study tests if a lung ultrasound can detect early signs of lung disease in people with rheumatoid arthritis. It may help you if you have certain risk factors, like being male, older, or a smoker.

Tours
NCT07208201Not yet recruiting
Lung fluid analysis for interstitial lung disease

This study uses a fluid sample taken from your lungs (called bronchoalveolar lavage) to understand the specific types of inflammation in different forms of interstitial lung disease. This may help doctors tailor better treatments for you in the future.

Hear when a new Interstitial Lung Disease (ILD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.